How Can Pharma Best Interact with ICER?
June 11, 2020
A new report from FirstWord looks at how pharma can best engage with the Institute for Clinical and Economic Review (ICER) as its influence in negotiations continues to increase.
The report, “Engaging with ICER: Lessons and Insights for Pharma,” includes insight from pharmaceutical industry experts who have experience dealing with ICER.
To learn more about the report, click here.
